Xellera Therapeutics delivers bespoke GMP manufacturing services—from early-stage development to large-scale commercial production—ensuring safe, high-quality cell and gene products. With in‑house infrastructure and expertise, we support CAR‑T, VST, iPSC, MSC, NK and dendritic cell therapies under current regulatory standards. https://www.xelleratherapeutics.com/services/custom-manufacturing-services/